195 related articles for article (PubMed ID: 22659236)
1. Phenylboronic acid-functionalized glycopolymeric nanoparticles for biomacromolecules delivery across nasal respiratory.
Zhang X; Wang Y; Zheng C; Li C
Eur J Pharm Biopharm; 2012 Sep; 82(1):76-84. PubMed ID: 22659236
[TBL] [Abstract][Full Text] [Related]
2. Amphiphilic glycopolymer nanoparticles as vehicles for nasal delivery of peptides and proteins.
Zheng C; Guo Q; Wu Z; Sun L; Zhang Z; Li C; Zhang X
Eur J Pharm Sci; 2013 Jul; 49(4):474-82. PubMed ID: 23648782
[TBL] [Abstract][Full Text] [Related]
3. Mucoadhesive and enzymatic inhibitory nanoparticles for transnasal insulin delivery.
Wang Y; Zhang X; Cheng C; Li C
Nanomedicine (Lond); 2014 Apr; 9(4):451-64. PubMed ID: 24910876
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of nasal absorption of insulin using chitosan nanoparticles.
Fernández-Urrusuno R; Calvo P; Remuñán-López C; Vila-Jato JL; Alonso MJ
Pharm Res; 1999 Oct; 16(10):1576-81. PubMed ID: 10554100
[TBL] [Abstract][Full Text] [Related]
5. Glucose-Sensitive Nanoparticles Based On Poly(3-Acrylamidophenylboronic Acid-Block-N-Vinylcaprolactam) For Insulin Delivery.
Wu JZ; Yang Y; Li S; Shi A; Song B; Niu S; Chen W; Yao Z
Int J Nanomedicine; 2019; 14():8059-8072. PubMed ID: 31632018
[TBL] [Abstract][Full Text] [Related]
6. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
Jain AK; Khar RK; Ahmed FJ; Diwan PV
Eur J Pharm Biopharm; 2008 Jun; 69(2):426-35. PubMed ID: 18295464
[TBL] [Abstract][Full Text] [Related]
7. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
9. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy.
Zhao YZ; Li X; Lu CT; Xu YY; Lv HF; Dai DD; Zhang L; Sun CZ; Yang W; Li XK; Zhao YP; Fu HX; Cai L; Lin M; Chen LJ; Zhang M
Acta Diabetol; 2012 Aug; 49(4):315-25. PubMed ID: 22124766
[TBL] [Abstract][Full Text] [Related]
10. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin.
Rastogi R; Anand S; Koul V
Drug Dev Ind Pharm; 2010 Nov; 36(11):1303-11. PubMed ID: 20849347
[TBL] [Abstract][Full Text] [Related]
11. Phenylboronate-diol crosslinked glycopolymeric nanocarriers for insulin delivery at physiological pH.
Guo Q; Wu Z; Zhang X; Sun L; Li C
Soft Matter; 2014 Feb; 10(6):911-20. PubMed ID: 24835766
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of temperature- and glucose-sensitive nanoparticles based on phenylboronic acid and N-vinylcaprolactam for insulin delivery.
Wu JZ; Bremner DH; Li HY; Sun XZ; Zhu LM
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1026-35. PubMed ID: 27612799
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
Sintov AC; Levy HV; Botner S
J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
15. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
17. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats.
Hou ZQ; Zhang ZX; Xu ZH; Zhang H; Tong ZF; Leng YS
Yao Xue Xue Bao; 2005 Jan; 40(1):57-64. PubMed ID: 15881329
[TBL] [Abstract][Full Text] [Related]
18. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement.
Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W
Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038
[TBL] [Abstract][Full Text] [Related]
19. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
[TBL] [Abstract][Full Text] [Related]
20. Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.
Zhang X; Zhang H; Wu Z; Wang Z; Niu H; Li C
Eur J Pharm Biopharm; 2008 Mar; 68(3):526-34. PubMed ID: 17881202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
